US2007203076A1PendingUtilityA1

Creatine ester pronutrient compounds and formulations

55
Individually held — no corporate assignee on recordPriority: Sep 14, 2000Filed: May 2, 2007Published: Aug 30, 2007
Est. expirySep 14, 2020(expired)· nominal 20-yr term from priority
Inventors:Jonathan L. VennerstromDonald W. Miller
A61P 9/00A61P 25/00A61P 25/16A61P 3/02A23V 2002/00A61P 21/00A61K 31/22A61K 31/7004A61K 31/198A23L 33/10A61K 31/66A61K 31/221A23K 20/142
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention describes a method for providing creatine to an animal, which includes receiving a creatine ester by the animal. The creatine ester is suitable for being modified by the animal to form creatine.

Claims

exact text as granted — not AI-modified
1 . A method for providing creatine to an animal, comprising orally receiving creatine ethyl ester and/or a salt of creatine ethyl ester by the animal in a form suitable for being modified by the animal into creatine.  
   
   
       2 . The method according to  claim 1 , wherein said animal is a human.  
   
   
       3 . The method according to  claim 1 , wherein said animal is livestock.  
   
   
       4 . The method according to  claim 1 , wherein the creatine ethyl ester and/or salt of creatine ethyl ester is in solid form.  
   
   
       5 . The method according to  claim 4 , wherein the solid form further comprises at least one of dextrose and phosphate.  
   
   
       6 . The method according to  claim 4 , wherein the solid form is configured as at least one of a tablet and a capsule.  
   
   
       7 . The method according to  claim 1 , wherein the creatine ethyl ester and/or salt of creatine ethyl ester is in a form suitable for liquid delivery.  
   
   
       8 . The method according to  claim 7 , wherein the creatine ethyl ester and/or salt of creatine ethyl ester is in the form of an aqueous solution or emulsion.  
   
   
       9 . The method according to  claim 1 , comprising orally receiving creatine ethyl ester by a human.  
   
   
       10 . The method according to  claim 1 , comprising orally receiving a creatine ethyl ester salt by a human.  
   
   
       11 . The method according to  claim 10 , comprising orally receiving creatine ethyl ester hydrochloride by a human.  
   
   
       12 . A food supplement, wherein said food supplement is suitable for administration to an animal and comprises creatine ethyl ester and/or a salt of creatine ethyl ester.  
   
   
       13 . The food supplement as claimed in  claim 12 , wherein said animal is a human.  
   
   
       14 . The food supplement as claimed in  claim 12 , wherein said supplement is in the form of a tablet or capsule.  
   
   
       15 . The food supplement of  claim 12 , wherein said food supplement further comprises at least one of dextrose and phosphate.  
   
   
       16 . The food supplement of  claim 13 , comprising creatine ethyl ester.  
   
   
       17 . The food supplement of  claim 13 , comprising creatine ethyl ester salt.  
   
   
       18 . The food supplement of  claim 13 , comprising creatine ethyl ester hydrochloride.  
   
   
       19 . The food supplement of  claim 13 , wherein said food supplement consists essentially of creatine ethyl ester and/or a salt of creatine ethyl ester.  
   
   
       20 . The food supplement of  claim 19 , wherein said food supplement further includes at least one of dextrose and phosphate.  
   
   
       21 . The food supplement of  claim 19 , which consists essentially of creatine ethyl ester.  
   
   
       22 . The food supplement of  claim 19 , which consists essentially of creatine ethyl ester salt.  
   
   
       23 . The food supplement of  claim 19 , which consists essentially of creatine ethyl ester hydrochloride.  
   
   
       24 . The food supplement of  claim 21 , wherein said food supplement further includes at least one of dextrose and phosphate.  
   
   
       25 . The food supplement of  claim 22 , wherein said food supplement further includes at least one of dextrose and phosphate.  
   
   
       26 . The food supplement of  claim 23 , wherein said food supplement further includes at least one of dextrose and phosphate.  
   
   
       27 . The food supplement of  claim 19 , wherein said supplement is in the form of a tablet or capsule.  
   
   
       28 . The food supplement as claimed in  claim 20 , wherein said supplement is in the form of a tablet or capsule.  
   
   
       29 . The food supplement as claimed in  claim 21 , wherein said supplement is in the form of a tablet or capsule.  
   
   
       30 . The food supplement as claimed in  claim 22 , wherein said supplement is in the form of a tablet or capsule.  
   
   
       31 . The food supplement as claimed in  claim 23 , wherein said supplement is in the form of a tablet or capsule.  
   
   
       32 . The food supplement as claimed in  claim 24 , wherein said supplement is in the form of a tablet or capsule.  
   
   
       33 . The food supplement as claimed in  claim 25 , wherein said supplement is in the form of a tablet or capsule.  
   
   
       34 . The food supplement as claimed in  claim 26 , wherein said supplement is in the form of a tablet or capsule.

Join the waitlist — get patent alerts

Track US2007203076A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.